Valuation: Guerbet

Market Cap 104M 120M 97.34M 89.04M 168M 11.41B 170M 1.14B 447M 5.7B 450M 440M 18.98B P/E 2026 *
-4.52x
P/E 2027 * 8.77x
Enterprise Value 480M 553M 449M 411M 775M 52.64B 786M 5.25B 2.06B 26.3B 2.07B 2.03B 87.54B EV / Sales 2026 *
0.63x
EV / Sales 2027 * 0.59x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 2.89%
1 day+0.40%
1 week+5.88%
Current month+2.44%
1 month-10.11%
3 months-31.77%
6 months-41.85%
Current year-46.38%
1 week 7.38
Extreme 7.38
7.56
1 month 7.05
Extreme 7.05
8.72
Current year 7.05
Extreme 7.05
14.92
1 year 7.05
Extreme 7.05
22.75
3 years 7.05
Extreme 7.05
39.4
5 years 7.05
Extreme 7.05
43.65
10 years 7.05
Extreme 7.05
89.68
Manager TitleAgeSince
Chief Executive Officer - 2026-02-01
Chief Executive Officer - 2025-09-21
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 2015-05-28
Director/Board Member 50 2017-05-18
Director/Board Member 51 2023-11-21
Change 5-day change 1-year change 3-year change Capi.($)
+8.50%+5.88% - - 117M
-1.71%-2.61%-13.65%-18.00% 13.72B
+1.52%+6.05%+50.31%-1.14% 4.18B
-2.67%+2.92%-38.57%-53.86% 1.3B
-2.21%+6.08%-34.71%-41.40% 1.23B
-1.33%-4.68%+29.06%+80.41% 1.17B
-1.39%+1.29%-46.47% - 961M
+6.39%+23.72%+38.91%+141.03% 543M
+2.36%+3.88%+64.93% - 338M
-0.24%+4.77%-62.24%+226.66% 257M
Average +0.13%+2.77%-1.38%+47.67% 2.63B
Weighted average by Cap. -0.91%-0.39%-2.24%-6.39%

Financials

2026 *2027 *
Net sales 764M 880M 715M 654M 1.24B 83.85B 1.25B 8.37B 3.28B 41.89B 3.3B 3.23B 139B 798M 920M 747M 684M 1.29B 87.62B 1.31B 8.74B 3.43B 43.78B 3.45B 3.38B 146B
Net income -35.8M -41.25M -33.52M -30.66M -57.89M -3.93B -58.65M -392M -154M -1.96B -155M -152M -6.54B 8.3M 9.56M 7.77M 7.11M 13.42M 911M 13.6M 90.92M 35.68M 455M 35.91M 35.13M 1.52B
Net Debt 376M 433M 352M 322M 607M 41.23B 615M 4.11B 1.61B 20.6B 1.63B 1.59B 68.57B 370M 427M 347M 317M 599M 40.65B 607M 4.06B 1.59B 20.31B 1.6B 1.57B 67.6B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change
26-08-06 7.560 +0.40%
26-08-05 €7.530 +0.80%
26-08-04 €7.470 -0.53%
26-08-03 €7.510 +1.76%
26-07-31 €7.380 +3.36%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
8.060EUR
Average target price
8.433EUR
Spread / Average Target
+4.63%

Quarterly revenue - Rate of surprise